Turkey has become a far more important patent jurisdiction than many foreign businesses first assume. The Turkish patent system is built on Law No. 6769 on Industrial Property, which entered into force on January 10, 2017 and now forms the main legal basis for patents and utility models in the country. The Turkish Patent and Trademark Office, known as TÜRKPATENT, is the central administrative authority responsible for registration, recordals, and related patent procedures, and it also acts as mediator in compulsory license matters and as an expert before the courts. Official data published by TÜRKPATENT further shows that patent activity remains strong: 11,394 domestic patent applications were filed in 2025, and Türkiye has also been highlighted by TÜRKPATENT as ranking 10th worldwide in domestic patent applications based on WIPO indicators.
For innovative companies, manufacturers, technology startups, research-driven exporters, and investors entering the Turkish market, this matters for a simple reason: a patent in Turkey is not merely a defensive filing. It can shape product launch timing, exclusivity, valuation, licensing leverage, distributor relationships, litigation posture, and even access to finance. WIPO’s recent country perspective on Türkiye describes the country as having a modern IP framework, specialized IP courts, enforcement agencies, and a broader policy focus on strengthening industrial property rights and commercialization. In other words, Turkey is not a peripheral filing venue. It is a functioning and commercially relevant patent jurisdiction.
A serious Turkish patent strategy, however, requires more than filing an application. Businesses must decide whether the invention is patentable at all, whether a utility model may be more suitable, whether to file directly or enter through the PCT national phase, whether employee invention rules affect ownership, how post-grant opposition risk should be managed, and how non-use and compulsory licensing could affect long-term exclusivity. Turkish patent law offers meaningful tools, but it also expects disciplined timing, careful drafting, and active portfolio management.
The legal framework of Turkish patent law
The principal legal source is Law No. 6769 on Industrial Property, and WIPO Lex identifies the statute as Turkey’s main industrial property law covering patents, utility models, trademarks, designs, geographical indications, and enforcement-related rules. TÜRKPATENT’s official “About Us” page confirms its role in registering patents and utility models, recording transfers and licenses, and acting as mediator in compulsory license procedures. This legal and institutional combination is important because patent strategy in Turkey depends not only on the wording of the statute, but also on the functioning of the Office and the procedural pathways available after filing.
Turkey is also integrated into the international patent system. The WIPO PCT Applicant’s Guide for Türkiye confirms that the country operates within the PCT framework, while WIPO’s member profile confirms Turkey’s relationship with the European Patent Convention. That means patent protection relevant to Turkey may be pursued through a direct national filing, a PCT filing followed by Turkish national-phase entry, or a European patent route combined with Turkish translation and publication requirements. For international applicants, this multi-route structure is a significant practical advantage.
What can be patented in Turkey?
Turkish patent law follows the classic three-part patentability model. Article 82 of Law No. 6769 states that inventions in all fields of technology are patentable if they are new, involve an inventive step, and are industrially applicable. This makes the Turkish system conceptually familiar to applicants who already work with European-style patent standards. It also means that commercial importance alone is never enough. The invention must still meet the statutory requirements of patentability.
Article 82 also sets clear limits by stating that certain subject matters are not treated as inventions for patent purposes when claimed as such. WIPO’s text of the law lists discoveries, scientific theories, mathematical methods, plans and methods for mental acts, business methods, game rules, computer programs as such, and presentations of information among the excluded subject matter. The same provision also excludes certain categories on public policy and technical grounds, including inventions contrary to public order or morality and specific medical and biological subject matter. For businesses in software, digital services, biotech, and health-tech, this means claim drafting in Turkey must be especially careful. A valuable innovation may fail if it is framed as an excluded concept rather than as a patentable technical solution.
This is why pre-filing legal analysis matters so much. A company may believe it has developed a commercially significant tool, workflow, or algorithm, yet Turkish patent protection will ultimately depend on how the invention is technically characterized and whether it survives scrutiny under Article 82. In practice, patentability in Turkey is not just about originality in a business sense. It is about legally recognized technical inventiveness.
Patent or utility model?
One of the most important strategic questions in Turkey is whether the innovation should be protected by a patent or a utility model. Under Article 101 of the Industrial Property Code, a patent lasts 20 years from the filing date, while a utility model lasts 10 years from the filing date, and those periods are not extendable. TÜRKPATENT’s current fee schedule reflects that same structure, listing annual patent fees through year 20 and utility model fees through year 10.
A utility model can be attractive where the invention is practical, structural, and commercially useful, but does not necessarily justify the time, cost, or scope of a full patent strategy. Yet the Turkish system draws important limits. Article 142 makes clear that utility model protection does not extend to inventions concerning chemical or biological substances or processes and their products, pharmaceutical substances or processes and their products, biotechnological inventions, or process inventions and products obtained through those processes. That means utility models can be useful for many device-based or mechanical innovations, but they are not a shortcut for chemistry, pharma, biotech, or process-heavy technologies.
There is also a procedural difference that matters in litigation planning. Patents in Turkey are subject to a post-grant opposition window under Article 99, while utility models follow a different grant path and do not use the same opposition mechanism. A business choosing between the two should therefore think not only about term and subject matter, but also about how quickly it wants a right, what kind of scrutiny it expects, and whether early enforceability or long-term resilience is the higher priority.
Filing routes for patent protection in Turkey
There are three principal ways to build patent protection relevant to Turkey. The first is a direct national filing before TÜRKPATENT. The second is a PCT application followed by national-phase entry in Turkey. The third is the European patent route, which remains important because publication of Turkish translations of European patent claims and specifications continues to play a role in local protection. TÜRKPATENT’s patent fee schedule expressly includes fees for PCT national-phase entry and for publication of European patent claims and specifications in Turkish.
For direct national filings, Article 90 sets out the filing requirements. A Turkish patent application must include the application form, description, claims, drawings referred to in the description or claims, abstract, and proof of payment of the filing fee. The law also allows the description, claims, abstract, and drawings initially to be filed in a foreign official language of certain states, subject to later compliance, which can be particularly useful where a company needs to secure a filing date quickly while coordinating translation work afterward.
For PCT filings, the WIPO PCT Applicant’s Guide for Türkiye currently states that the standard national-phase deadline is 30 months from the priority date, with entry possible up to 33 months if the applicant pays the extension fee. The same guide states that the Turkish translation of the international application must be furnished within two months from entry into the national phase and that the Office permits reinstatement of rights under the “due care” criterion. TÜRKPATENT’s current fee schedule separately lists the national-phase entry fee, the additional time fee for entering the national phase, and the restoration fee after 33 months. These details are critical because missed national-phase deadlines are among the most expensive and avoidable patent losses in cross-border practice.
The European patent route should also not be underestimated. TÜRKPATENT’s fee schedule includes publication fees for the claims of a European patent application, publication of the European patent specification, and additional time for filing the Turkish translation of the European patent specification. In practice, this means applicants prosecuting before the EPO must still handle Turkish translation and publication steps carefully if they want effective local protection and enforcement readiness in Turkey.
Patent prosecution in Turkey
Once a national application is filed, prosecution before TÜRKPATENT follows a structured process. The Office reviews the filing for formal compliance, and Article 95 indicates that if formal deficiencies exist, the applicant is typically given two months to remedy them; otherwise the application may be rejected. If the application is formally complete, the process moves toward the search phase. Article 96 states that the applicant must request a search report and pay the fee within 12 months from the filing date, otherwise the application is deemed withdrawn. TÜRKPATENT’s fee schedule reflects this by listing both search report and examination report fees, including urgent search options in some cases.
Substantive examination is where many applications are truly tested. The law provides for examination after the search stage, and if the examiner concludes that the application and invention comply with the Code, the patent may be granted. If not, the Office can reject the application. The statutory structure also allows further examination rounds in limited form, and TÜRKPATENT’s fee schedule includes fees for the second and third examination reports, confirming that prosecution can involve multiple substantive interactions. Patent applicants in Turkey therefore need to budget not just for filing, but for prosecution as an active process that may require amendment, argument, and technical narrowing.
This has practical implications for foreign applicants. A filing that is technically sound in one jurisdiction may still require adaptation in Turkey, particularly where local formalities, translations, or prosecution timing differ. A patent strategy that assumes Turkey will merely mirror another jurisdiction can easily underperform.
Post-grant opposition in Turkey
One of the most significant features of Turkish patent law is the post-grant opposition procedure. Article 99 provides that third parties may oppose a granted patent within six months from publication of the grant decision in the Bulletin. The grounds include lack of patentability under Articles 82 and 83, insufficient disclosure under Article 92, and subject matter extending beyond the original application. If no opposition is filed, or if the opposition is not validly made, the decision on grant becomes final.
This six-month window is commercially important because a grant in Turkey is not always the end of the administrative battle. Competitors may wait until grant to assess the final claim set and then attack the patent on validity grounds. Businesses launching high-value products in Turkey should therefore treat grant as a milestone, not as the end of risk. A strong post-grant defense file, clear disclosure, and coherent prosecution history can make the difference between a durable Turkish patent and a right that quickly becomes fragile.
Scope of patent protection and infringement
Article 85 sets out the scope of patent protection in Turkey. It states that the patent owner benefits from the patent right without discrimination based on the place of invention, field of technology, or whether products are imported or domestically produced. It also gives the patent owner the right to prevent, if done without permission, the manufacture, sale, use, or importation of the patented product, possession of that product for commercial purposes, use of a patented process, and even the offering of a patented process to others where such use is known or should be known to be prohibited. This is a broad and commercially meaningful exclusionary right.
These rights matter because Turkish patent litigation is not only about final damages judgments. It is often about stopping a competing launch, cutting off import flows, shaping settlement leverage, or forcing licensing discussions from a position of strength. WIPO’s country report on Türkiye also notes the presence of specialized IP courts and enforcement institutions, which reinforces the practical enforceability of registered industrial property rights in the country.
Turkish law also gives meaningful protection before final grant in some situations. The Code provides that once the application has reached the publication stage, the applicant may bring an infringement action, and if the alleged infringer was informed of the application and its scope, publication is not decisive. Where the court finds bad faith, infringement may even be recognized before publication. This can be strategically important where a competitor copies a disclosed invention during the application phase and assumes that the applicant must wait passively until grant.
Employee inventions and ownership risks
Patent ownership in Turkey must be analyzed carefully, especially in technology companies, industrial groups, universities, and R&D-heavy businesses. Article 113 draws a distinction between service inventions and free inventions. A service invention is one made by an employee during the employment relationship in connection with the activity the employee is obliged to perform, or based substantially on the experience and work of the enterprise or public administration. Inventions outside that category are treated as free inventions. This distinction is not academic. It can determine whether the employer truly owns the patent asset it believes it owns.
In transactional practice, this becomes one of the most common hidden risks. A startup may believe its core invention belongs to the company, while the underlying employment or consultancy framework may be incomplete or poorly documented. In Turkey, as elsewhere, a patent can be weakened not only by invalidity arguments, but also by ownership defects. For that reason, invention assignment clauses, employee notification systems, and internal innovation policies should be aligned with the statutory framework before a valuable filing is monetized or litigated.
Compulsory licensing and non-use
A patent owner in Turkey cannot assume that the right can remain purely dormant forever. TÜRKPATENT’s official description of its duties confirms that the Office acts as mediator in compulsory license procedures, and the Industrial Property Code recognizes several compulsory-license scenarios. Among the most practically important is non-use. Article 130 states that the patent owner or authorized person is obliged to use the invention protected by the patent, taking market conditions and circumstances beyond the owner’s control into account. It further provides that once the later of three years from publication of the grant decision or four years from the filing date has expired, interested persons may request a compulsory license if the invention has not begun to be used, if no serious and real attempts at use have been made, or if use remains insufficient to meet national market needs.
This is a major strategic point for international businesses. A Turkish patent should not be treated only as a blocking right with no commercial implementation plan. Where a right holder does not meaningfully exploit the invention or prepare credible market use, long-term exclusivity can become more vulnerable. Even where compulsory licensing is not ultimately ordered, the legal possibility affects how Turkish patents should be valued and managed in sectors involving pharmaceuticals, industrial manufacturing, essential technologies, or public-interest-sensitive products.
Invalidity and post-grant vulnerability
Even after grant, Turkish patents remain open to court-based invalidity challenges. The Code provides for invalidity where the invention does not meet patentability requirements, where disclosure is insufficient, where the patent extends beyond the original application, or where the patent holder lacked entitlement. The law also states that a final invalidity decision has retroactive effect, meaning the protection is treated as though it never validly arose, subject to limited protections for finalized judgments and executed contracts. This is why prosecution quality matters so deeply. A Turkish patent that appears strong on paper may collapse if the disclosure is thin, the claims overreach, or ownership is defective.
For that reason, companies should think about invalidity risk from day one. A claim set that is too broad may impress internally but fail in court. A filing that omits technical detail may speed drafting but weaken sufficiency. A prosecution amendment that solves one examination problem may create later inconsistency. In Turkish patent practice, as in other serious systems, the quality of the original application often decides the future enforcement value of the right.
Licensing, transfer, and commercialization
Patent rights in Turkey are not only litigation tools. They are also commercial assets. TÜRKPATENT’s official materials confirm that the Office records license and transfer agreements, and its patent fee schedule includes recordal and publication fees for assignments, licenses, inheritance transfers, structural changes, offers to grant licenses, and pledges or security interests. WIPO’s country report on Türkiye also notes that the 2017 legal framework supported the use of IP rights in financing and commercialization structures, including collateralization and broader IP-backed economic use.
This matters particularly for startups, manufacturing groups, and investors. A Turkish patent portfolio can support licensing revenue, partnership negotiations, collateral discussions, or M&A valuation. But that only works if title, prosecution history, employee-invention compliance, maintenance status, and recordals are all clean. A patent that exists in name but is poorly maintained or weakly documented will rarely deliver the commercial leverage businesses expect.
Final thoughts
Patent protection in Turkey is sophisticated, practical, and increasingly important. The country has a modern industrial property statute, an active patent office, PCT access, a European patent pathway, post-grant opposition for patents, utility model protection for suitable technologies, and a court and enforcement structure capable of giving real commercial effect to registered rights. Recent official statistics also confirm that Türkiye is not a dormant or marginal jurisdiction; it is a growing patent environment with substantial filing activity.
For businesses that want to operate seriously in the Turkish market, the right time to think about patents is before disclosure, before launch, and before conflicts arise. The best results usually come from a strategy that combines patentability analysis, the correct filing route, careful drafting, prosecution discipline, ownership review, enforcement planning, and commercialization readiness. In Turkey, a patent is most valuable when it is treated not as a certificate to obtain, but as a business asset to build, maintain, and use intelligently.
Yanıt yok